Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Virpax Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:VRPX | Benzinga

Q: What sector and industry does Virpax Pharmaceuticals (VRPX) operate in?

Virpax Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Explore Virpax Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VRPX.

Open	-
Close	-
Volume / Avg.	36.43K / 5.52M
Day Range	- - -
52 Wk Range	0.18 - 5.48
Market Cap	$3.68M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	8.71%
Days to Cover	1

Recent News

US Stocks Likely To Open Higher Following A Sell-Off, 'This Choppy Start To 2025 Isn't Abnormal. Don't Panic,' Says Expert Highlighting Seasonal Weakness In The First Quarter After Elections

U.S. stock futures rose on Friday following Thursday's sell-off. Futures advanced except the small-cap gauge Russell 2000.

Rishabh Mishra

Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate

Virpax completed a U.S. Army-backed Probudur study, showing potential for prolonged pain relief and reduced opioid use in surgical recovery.

Vandana Singh

Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	36.43K / 5.52M
Day Range	- - -
52 Wk Range	0.18 - 5.48
Market Cap	$3.68M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	8.71%
Days to Cover	1

About Virpax Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Virpax Pharmaceuticals (VRPX) stock?

You can purchase shares of Virpax Pharmaceuticals (NASDAQ:VRPX) through any online brokerage.

View our list of the best stock brokerages

Who are Virpax Pharmaceuticals (VRPX) competitors?

Other companies in Virpax Pharmaceuticals’s space includes: 60 Degrees (NASDAQ:SXTP), Addex Therapeutics (NASDAQ:ADXN), Akanda (NASDAQ:AKAN), Jaguar Health (NASDAQ:JAGX) and Sonoma Pharmaceuticals (NASDAQ:SNOA).

What is the forecast, or price target, for Virpax Pharmaceuticals (VRPX) stock?

There is no analysis for Virpax Pharmaceuticals to provide a consensus price target.

What is the current price for Virpax Pharmaceuticals (VRPX)?

The stock price for Virpax Pharmaceuticals (NASDAQ: VRPX) is $0.2008 last updated March 10, 2025 at 4:01 AM EDT.

Does Virpax Pharmaceuticals (VRPX) pay a dividend?

There are no upcoming dividends for Virpax Pharmaceuticals.

When is Virpax Pharmaceuticals (NASDAQ:VRPX) reporting earnings?

Virpax Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 12, 2025.

Is Virpax Pharmaceuticals (VRPX) going to split?

There is no upcoming split for Virpax Pharmaceuticals.

What sector and industry does Virpax Pharmaceuticals (VRPX) operate in?

Virpax Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Virpax Pharmaceuticals Stock Price, Quotes and Forecasts

Virpax Pharmaceuticals (VRPX) Forecast